AbbVie lands FDA approval for next-generation Parkinson’s drug, Juvmo

Juvmo was designed to offer a reduction in motor symptoms, while reducing non-motor side effects, through its more selective ...
michaeljfox.org

FDA Approves Tavapadon for Parkinson’s Motor Symptoms

Tavapadon (Juvmo) is a new once-daily pill for Parkinson’s motor symptoms. Here’s how it works, who it may help and what to ...
BioSpace

AbbVie wins FDA approval for Parkinson’s drug from $8.7B Cerevel takeover

In the Phase 3 TEMPO program, AbbVie’s Juvmo elicited significant improvements in motor symptoms and prolonged periods with ...

FDA Nod For JUVMO Parkinson’s Drug Could Be A Game Changer For AbbVie (ABBV)

AbbVie recently received U.S. FDA approval for JUVMO (tavapadon) tablets, the first and only selective D1/D5 receptor agonist ...
Medscape

FDA Approves First-In-Class Med for Parkinson's Disease

Today's FDA approval of tavapadon makes it the first selective D1/D5 receptor agonist for the treatment of adults with Parkinson's disease.

"I can walk, so I'm fine" is not enough—The "invisible symptoms" of Parkinson's disease from the perspective of a caregiver

When it comes to Parkinson's disease, we inevitably focus on "movement," such as tremors, freezing of gait, and rigidity.But ...
Hosted on MSN

4 Parkinson’s disease symptoms that can show up decades before a diagnosis

Many people think of a tremor as the quintessential warning sign of Parkinson’s disease. But other symptoms — many of them not involving changes in movement — can appear much earlier than what’s known ...

Ask Mayo Clinic: Learn the key difference between essential tremor and Parkinson's disease

Some people live with essential tremor for years and organically find ways to adapt. Others may begin avoiding activities.